Key facts
- This page summarizes ADVENT INTERNATIONAL, L.P.'s Form 4 filing for Definitive Healthcare Corp. (DH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Nov 2021, 16:00.
ADVENT INTERNATIONAL, L.P. - 22 Nov 2021 Form 4 Insider Report for Definitive Healthcare Corp. (DH)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- DH
- Reported as of
- 22 Nov 2021
- Net transaction value
- -$73,053,808
- SEC form
- 4
- Accepted by SEC
- 24 Nov 2021, 16:00:53 UTC
- Prior SEC filing
- 12 Oct 2021
- Next SEC filing
- 29 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- ADVENT INTERNATIONAL CORPORATION, By: /s/ Neil Crawford, Name: Neil Crawford, Title: Director, Fund Administration
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
ADVENT INTERNATIONAL, L.P. filed Form 4 for Definitive Healthcare Corp. (DH) on 24 Nov 2021.
Change
- Previous filing in this sequence was filed on 12 Oct 2021.
- Current net transaction value: -$73,053,808.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DH
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- $73,053,808
- Shares
- -2,102,873
- Change %
- -3.3%
- Price
- $34.74
- Shares after
- 62,493,676
- Date
- 22 Nov 2021
- Ownership
- See Notes
- Footnotes
- F1, F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
See Exhibit 99.1 for text of footnote (1).
Footnote F2
See Exhibit 99.1 for text of footnote (2).
Footnote F3
See Exhibit 99.1 for text of footnote (3).
Footnote F4
See Exhibit 99.1 for text of footnote (4).
SEC remarks
Christopher Egan, a Managing Partner of Advent and Lauren Young, a Managing Director of Advent (together, the "Advent Directors"), each serve on the board of directors of the Issuer, and have been deputized to represent the Reporting Persons on the board of directors. By virtue of the Advent Directors' representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons may be deemed directors by deputization of the Issuer. The Advent Directors have filed separate Section 16 reports disclosing securities of the Issuer that they may be deemed to beneficially own for Section 16 purposes. Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated by reference. Form 5 of 5: This Form 4 is the fifth of five Forms 4 being filed relating to the same event. The Form 4 has been split into multiple filings because there are more than 10 Reporting Persons total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. Each Form 4 will be filed by Designated Filer Advent International Corporation.